340 related articles for article (PubMed ID: 7918471)
1. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis.
Uchida K; Toyokuni S; Nishikawa K; Kawakishi S; Oda H; Hiai H; Stadtman ER
Biochemistry; 1994 Oct; 33(41):12487-94. PubMed ID: 7918471
[TBL] [Abstract][Full Text] [Related]
2. Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein.
Requena JR; Fu MX; Ahmed MU; Jenkins AJ; Lyons TJ; Baynes JW; Thorpe SR
Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):317-25. PubMed ID: 9078279
[TBL] [Abstract][Full Text] [Related]
3. Identification of 4-hydroxy-2-nonenal-histidine adducts that serve as ligands for human lectin-like oxidized LDL receptor-1.
Kumano-Kuramochi M; Shimozu Y; Wakita C; Ohnishi-Kameyama M; Shibata T; Matsunaga S; Takano-Ishikawa Y; Watanabe J; Goto M; Xie Q; Komba S; Uchida K; Machida S
Biochem J; 2012 Feb; 442(1):171-80. PubMed ID: 22077443
[TBL] [Abstract][Full Text] [Related]
4. Covalent binding of oxidized cholesteryl esters to protein: implications for oxidative modification of low density lipoprotein and atherosclerosis.
Kawai Y; Saito A; Shibata N; Kobayashi M; Yamada S; Osawa T; Uchida K
J Biol Chem; 2003 Jun; 278(23):21040-9. PubMed ID: 12663661
[TBL] [Abstract][Full Text] [Related]
5. 4-Hydroxy-2-nonenal-trapping ELISA: direct evidence for the release of a cytotoxic aldehyde from oxidized low density lipoproteins.
Uchida K; Osawa T; Hiai H; Toyokuni S
Biochem Biophys Res Commun; 1995 Jul; 212(3):1068-73. PubMed ID: 7626094
[TBL] [Abstract][Full Text] [Related]
6. Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies.
Uchida K; Itakura K; Kawakishi S; Hiai H; Toyokuni S; Stadtman ER
Arch Biochem Biophys; 1995 Dec; 324(2):241-8. PubMed ID: 8554315
[TBL] [Abstract][Full Text] [Related]
7. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.
Palinski W; Ylä-Herttuala S; Rosenfeld ME; Butler SW; Socher SA; Parthasarathy S; Curtiss LK; Witztum JL
Arteriosclerosis; 1990; 10(3):325-35. PubMed ID: 1693068
[TBL] [Abstract][Full Text] [Related]
8. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation.
Steinbrecher UP; Lougheed M; Kwan WC; Dirks M
J Biol Chem; 1989 Sep; 264(26):15216-23. PubMed ID: 2768257
[TBL] [Abstract][Full Text] [Related]
9. Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages.
Hoff HF; O'Neil J; Chisolm GM; Cole TB; Quehenberger O; Esterbauer H; Jürgens G
Arteriosclerosis; 1989; 9(4):538-49. PubMed ID: 2751482
[TBL] [Abstract][Full Text] [Related]
10. Proatherogenic effects of 4-hydroxynonenal.
Nègre-Salvayre A; Garoby-Salom S; Swiader A; Rouahi M; Pucelle M; Salvayre R
Free Radic Biol Med; 2017 Oct; 111():127-139. PubMed ID: 28040472
[TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein has an enormous capacity to bind (E)-4-hydroxynon-2-enal (HNE): detection and characterization of lysyl and histidyl adducts containing multiple molecules of HNE.
Annangudi SP; Deng Y; Gu X; Zhang W; Crabb JW; Salomon RG
Chem Res Toxicol; 2008 Jul; 21(7):1384-95. PubMed ID: 18570390
[TBL] [Abstract][Full Text] [Related]
12. The effect of high-density lipoproteins on the formation of lipid/protein conjugates during in vitro oxidation of low-density lipoprotein.
Sangvanich P; Mackness B; Gaskell SJ; Durrington P; Mackness M
Biochem Biophys Res Commun; 2003 Jan; 300(2):501-6. PubMed ID: 12504112
[TBL] [Abstract][Full Text] [Related]
13. Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination.
Chen Q; Esterbauer H; Jürgens G
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):249-54. PubMed ID: 1280111
[TBL] [Abstract][Full Text] [Related]
14. Polyclonal antibodies to a fluorescent 4-hydroxy-2-nonenal (HNE)-derived lysine-lysine cross-link: characterization and application to HNE-treated protein and in vitro oxidized low-density lipoprotein.
Xu G; Liu Y; Sayre LM
Chem Res Toxicol; 2000 May; 13(5):406-13. PubMed ID: 10813658
[TBL] [Abstract][Full Text] [Related]
15. Copper ions promote peroxidation of low density lipoprotein lipid by binding to histidine residues of apolipoprotein B100, but they are reduced at other sites on LDL.
Wagner P; Heinecke JW
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3338-46. PubMed ID: 9409331
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry-based proteomics of oxidative stress: Identification of 4-hydroxy-2-nonenal (HNE) adducts of amino acids using lysozyme and bovine serum albumin as model proteins.
Aslebagh R; Pfeffer BA; Fliesler SJ; Darie CC
Electrophoresis; 2016 Oct; 37(20):2615-2623. PubMed ID: 27184861
[TBL] [Abstract][Full Text] [Related]
17. The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct.
Toyokuni S; Miyake N; Hiai H; Hagiwara M; Kawakishi S; Osawa T; Uchida K
FEBS Lett; 1995 Feb; 359(2-3):189-91. PubMed ID: 7867796
[TBL] [Abstract][Full Text] [Related]
18. Protein modification by lipid peroxidation products: formation of malondialdehyde-derived N(epsilon)-(2-propenol)lysine in proteins.
Uchida K; Sakai K; Itakura K; Osawa T; Toyokuni S
Arch Biochem Biophys; 1997 Oct; 346(1):45-52. PubMed ID: 9328283
[TBL] [Abstract][Full Text] [Related]
19. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes.
Uchida K; Szweda LI; Chae HZ; Stadtman ER
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8742-6. PubMed ID: 8378358
[TBL] [Abstract][Full Text] [Related]
20. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions.
Requena JR; Fu MX; Ahmed MU; Jenkins AJ; Lyons TJ; Thorpe SR
Nephrol Dial Transplant; 1996; 11 Suppl 5():48-53. PubMed ID: 9044307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
